Literature DB >> 8592061

Molecular basis of recessive dystrophic epidermolysis bullosa: genotype/phenotype correlation in a case of moderate clinical severity.

H Shimizu1, J A McGrath, A M Christiano, T Nishikawa, J Uitto.   

Abstract

Mutations within the gene encoding the anchoring fibril protein type VII collagen (COL7A1) have recently been established as the pathogenetic basis for the inherited blistering skin disorder, dystrophic epidermolysis bullosa. We report a patient with a moderately severe phenotype of recessive dystrophic epidermolysis bullosa. We report a patient with a moderately severe phenotype of recessive dystrophic epidermolysis bullosa, in whom COL7A1 mutations have been identified on both alleles. The patient is a 5-y-old Japanese male of nonconsanguineous parents, with clinical features including generalized trauma-induced blistering since birth, complete loss of nails, and partial fusion of the fingers and toes. Immunofluorescence microscopy examination of the dermal-epidermal junction in the patient's skin revealed near-normal intensity staining with an antitype VII collagen antibody (LH7:2). Transmission electron microscopy showed a reduced number of thin, poorly-formed anchoring fibrils. PCR amplification of genomic DNA, followed by heteroduplex analysis, and nucleotide sequencing demonstrated that the patient was a compound heterozygote for a nonsense mutation (E2858X) within the NC-2 domain of type VII collagen and a missense mutation (G2576R) within the type VII collagen triple helix. Both mutations were verified by restriction endonuclease digestion. Information about these mutations advances our understanding of genotype-phenotype correlations in dystrophic epidermolysis bullosa, and further delineates the mechanisms involved in dermal-epidermal dysadhesion.

Entities:  

Mesh:

Year:  1996        PMID: 8592061     DOI: 10.1111/1523-1747.ep12329600

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  14 in total

1.  Characterization of 18 new mutations in COL7A1 in recessive dystrophic epidermolysis bullosa provides evidence for distinct molecular mechanisms underlying defective anchoring fibril formation.

Authors:  A Hovnanian; A Rochat; C Bodemer; E Petit; C A Rivers; C Prost; S Fraitag; A M Christiano; J Uitto; M Lathrop; Y Barrandon; Y de Prost
Journal:  Am J Hum Genet       Date:  1997-09       Impact factor: 11.025

2.  Epidermolysis bullosa. II. Type VII collagen mutations and phenotype-genotype correlations in the dystrophic subtypes.

Authors:  Roslyn Varki; Sara Sadowski; Jouni Uitto; Ellen Pfendner
Journal:  J Med Genet       Date:  2006-09-13       Impact factor: 6.318

3.  Genetic studies of 20 Japanese families of dystrophic epidermolysis bullosa.

Authors:  Daisuke Sawamura; Maki Goto; Kana Yasukawa; Kazuko Sato-Matsumura; Hideki Nakamura; Kei Ito; Hiroyuki Nakamura; Yuki Tomita; Hiroshi Shimizu
Journal:  J Hum Genet       Date:  2005-09-28       Impact factor: 3.172

4.  COL7A1 mutation G2037E causes epidermal retention of type VII collagen.

Authors:  Daisuke Sawamura; Kazuko Sato-Matsumura; Satoko Shibata; Akari Tashiro; Masutaka Furue; Maki Goto; Kaori Sakai; Masashi Akiyama; Hideki Nakamura; Hiroshi Shimizu
Journal:  J Hum Genet       Date:  2006-03-24       Impact factor: 3.172

Review 5.  Lessons from skin blistering: molecular mechanisms and unusual patterns of inheritance?

Authors:  A S Paller
Journal:  Am J Pathol       Date:  1996-06       Impact factor: 4.307

6.  Bone marrow transplant with post-transplant cyclophosphamide for recessive dystrophic epidermolysis bullosa expands the related donor pool and permits tolerance of nonhaematopoietic cellular grafts.

Authors:  C L Ebens; J A McGrath; K Tamai; A Hovnanian; J E Wagner; M J Riddle; D R Keene; T E DeFor; R Tryon; M Chen; D T Woodley; K Hook; J Tolar
Journal:  Br J Dermatol       Date:  2019-06-28       Impact factor: 9.302

7.  Induced pluripotent stem cells from individuals with recessive dystrophic epidermolysis bullosa.

Authors:  Jakub Tolar; Lily Xia; Megan J Riddle; Chris J Lees; Cindy R Eide; Ron T McElmurry; Matthias Titeux; Mark J Osborn; Troy C Lund; Alain Hovnanian; John E Wagner; Bruce R Blazar
Journal:  J Invest Dermatol       Date:  2010-12-02       Impact factor: 8.551

8.  Bone marrow transplantation for recessive dystrophic epidermolysis bullosa.

Authors:  John E Wagner; Akemi Ishida-Yamamoto; John A McGrath; Maria Hordinsky; Douglas R Keene; David T Woodley; Mei Chen; Megan J Riddle; Mark J Osborn; Troy Lund; Michelle Dolan; Bruce R Blazar; Jakub Tolar
Journal:  N Engl J Med       Date:  2010-08-12       Impact factor: 91.245

9.  Characterization of molecular mechanisms underlying mutations in dystrophic epidermolysis bullosa using site-directed mutagenesis.

Authors:  David T Woodley; Yingping Hou; Sabrina Martin; Wei Li; Mei Chen
Journal:  J Biol Chem       Date:  2008-04-30       Impact factor: 5.157

10.  Glycine substitutions in the triple-helical region of type VII collagen result in a spectrum of dystrophic epidermolysis bullosa phenotypes and patterns of inheritance.

Authors:  A M Christiano; J A McGrath; K C Tan; J Uitto
Journal:  Am J Hum Genet       Date:  1996-04       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.